|

Antineoplastic Vaccine Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Cancer Vaccine, Neoplasm Vaccine, Tumor Vaccine, cancer treatment vaccine

Pipeline

Phase 1/2: 1

Top Sponsors

  • Tianhong Li1

Indications

  • Recurrent Malignant Solid Neoplasm1
  • Recurrent Adenocarcinoma1
  • Metastatic Malignant Solid Neoplasm1
  • Metastatic Adenocarcinoma1
  • Advanced Malignant Solid Neoplasm1

Sacramento, California1 trial

A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma

University of California Davis Comprehensive Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.